Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 11
1999 15
2000 22
2001 57
2002 64
2003 83
2004 99
2005 104
2006 106
2007 106
2008 118
2009 96
2010 95
2011 96
2012 116
2013 102
2014 107
2015 133
2016 111
2017 112
2018 107
2019 91
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,754 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Routy B, et al. Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2. Science. 2018. PMID: 29097494
Small Molecule CXCR3 Antagonists.
Andrews SP, Cox RJ. Andrews SP, et al. J Med Chem. 2016 Apr 14;59(7):2894-917. doi: 10.1021/acs.jmedchem.5b01337. Epub 2015 Nov 4. J Med Chem. 2016. PMID: 26535614 Review.
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
Reynders N, Abboud D, Baragli A, Noman MZ, Rogister B, Niclou SP, Heveker N, Janji B, Hanson J, Szpakowska M, Chevigné A. Reynders N, et al. Cells. 2019 Jun 18;8(6):613. doi: 10.3390/cells8060613. Cells. 2019. PMID: 31216755 Free PMC article. Review.
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ Jr, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G. Dangaj D, et al. Cancer Cell. 2019 Jun 10;35(6):885-900.e10. doi: 10.1016/j.ccell.2019.05.004. Cancer Cell. 2019. PMID: 31185212 Free PMC article.
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.
Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger AK, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G. Weigold F, et al. Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8. Arthritis Res Ther. 2018. PMID: 29566745 Free PMC article.
Chemokine Receptors CXCR3 and CCR6 and Their Ligands in the Liver and Blood of Patients with Chronic Hepatitis C.
Arsent'eva NA, Semenov AV, Lyubimova NE, Ostankov YV, Elezo DS, Kudryavtsev IV, Basina VV, Esaulenko EV, Kozlov KV, Zhdanov KV, Totolyan AA. Arsent'eva NA, et al. Bull Exp Biol Med. 2015 Dec;160(2):252-5. doi: 10.1007/s10517-015-3142-z. Epub 2015 Dec 3. Bull Exp Biol Med. 2015. PMID: 26631389
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes.
Fallahi P, Corrado A, Di Domenicantonio A, Frenzilli G, Antonelli A, Ferrari SM. Fallahi P, et al. Curr Drug Targets. 2016;17(5):515-9. doi: 10.2174/1389450115666141229153949. Curr Drug Targets. 2016. PMID: 25547908 Review.
1,754 results
Jump to page
Feedback